“Obesity is the number-one health problem in the United States because it negatively affects our population’s health more than any other condition,” said Kaiser Permanente Washington Health Research Institute Senior Investigator David Arterburn, MD, MPH. Kaiser Permanente Washington researchers are doing practical research to learn how doctors, patients, families, employers, and policymakers can best work together to prevent and treat obesity.
“We’re focusing on three ways to halt the obesity epidemic,” said Senior Investigator Dori Rosenberg, PhD, MPH. “We’re helping to change obesity-promoting environments, bringing evidence-based prevention and treatment programs into health care systems, and helping people develop lifelong healthy diet and activity habits.”
Kaiser Permanente Washington obesity research areas include:
“Obesity is caused by many factors, so at Kaiser Permanente Washington, we’re working on many levels,” said Paula Lozano, MD, MPH, a senior investigator and Kaiser Permanente Washington’s assistant medical director for preventive care. “We’re improving health care to help people who are obese now. But since obesity is a societal problem, we’re also studying how to change our homes and workplaces and neighborhoods to create more healthy environments.”
Jones-Smith JC, Knox MA, Chakrabarti S, Wallace J, Walkinshaw L, Mooney SJ, Godwin J, Arterburn DE, Eavey J, Chan N, Saelens BE. Sweetened beverage tax implementation and change in body mass index among children in Seattle. JAMA Netw Open. 2024;7(5):e2413644. doi: 10.1001/jamanetworkopen.2024.13644. PubMed
Clennin M, Reifler L, Goodman O, Brown MC, Vupputuri S, Daugherty SL, Schootman M. Association of housing instability with obesity status among insured adults. Am J Prev Med. 2024 Apr 20:S0749-3797(24)00135-1. doi: 10.1016/j.amepre.2024.04.008. [Epub ahead of print]. PubMed
Henderson K, Lewis, Sloan CE, Bessesen DH, Arterburn D. Effectiveness and safety of drugs for obesity. BMJ. 2024;384:e072686. doi: 10.1136/bmj-2022-072686. PubMed
Courcoulas AP, Patti ME, Hu B, Arterburn DE, Simonson DC, Gourash WF, Jakicic JM, Vernon AH, Beck GJ, Schauer PR, Kashyap SR, Aminian A, Cummings DE, Kirwan JP. Long-term outcomes of medical management vs bariatric surgery in type 2 diabetes. JAMA. 2024;331(8):654-664. doi: 10.1001/jama.2024.0318. PubMed
Argetsinger S, LeCates RF, Zhang F, Ross-Degnan D, Wharam JF, Arterburn DE, Fernandez A, Lewis KH. Comparison of health care costs following sleeve gastrectomy versus Roux-en-Y gastric bypass among patients with type 2 diabetes. Obesity (Silver Spring). 2024;32(4):691-701. doi: 10.1002/oby.23997. Epub 2024 Feb 13. PubMed
David E. Arterburn, MD, MPHSenior Investigator |
Allen Cheadle, PhDSenior Investigator, KPWHRI; Senior Research Associate, CCHE |
Andrea J. Cook, PhDSenior Biostatistics Investigator |
Maricela Cruz, PhDAssistant Biostatistics Investigator |
Nicole M. Gatto, PhD, MPHPrincipal Collaborative Scientist |
Beverly B. Green, MD, MPHSenior Investigator |
Mikael Anne Greenwood-Hickman, MPHSenior Collaborative Scientist |
Laurel Hansell, MA, MPHCollaborative Scientist |
Paula Lozano, MD, MPHSenior Investigator; Director, ACT Center |
Dori E. Rosenberg, PhD, MPHSenior Investigator |
Gregory E. Simon, MD, MPHSenior Investigator |